John Noseworthy biography

Dr. John H. Noseworthy, M.D. is Independent Director of the Company. Dr. Noseworthy served as president and CEO of Mayo Clinic from 2009 until his retirement in 2018, leading one of the largest and most prestigious academic health systems in the United States, with $12 billion in annual revenues and 68,000 employees. With a focus on caring for patients with serious, complex illnesses, Mayo Clinic operates in five states and cares for more than 1 million people a year, from all 50 states and nearly 140 countries. Mayo Clinic is ranked No. 1 in the nation by U.S. News & World Report . Prior to his appointment as CEO, Dr. Noseworthy served as chair of Mayo Clinic’s Department of Neurology, medical director of the Department of Development and vice chair of the Mayo Clinic Rochester Executive Board. Dr. Noseworthy received his M.D. degree from Dalhousie University in Halifax, Nova Scotia, Canada. He completed his neurology training at Dalhousie University and the University of Western Ontario, and a research fellowship at Harvard Medical School. He joined Mayo Clinic in 1990. He is the author of more than 150 research papers, chapters, editorials and several books, including the three-volumeNeurological Therapeutics: Principles and Practice, now in its second edition. He also served as editor-in-chief of Neurology , the official journal of the American Academy of Neurology.

How old is John Noseworthy?

John Noseworthy is 67, he’s been the Independent Director of UnitedHealth since 2019. There are 3 older and 10 younger executives at UnitedHealth. The oldest executive at UnitedHealth Group, Inc. is William Ballard, 78, who is the Independent Director.

What’s John Noseworthy’s mailing address?

John’s mailing address filed with the SEC is C/O UNITEDHEALTH GROUP, 9900 BREN ROAD EAST, MINNETONKA, MN, 55343.

Insider trading at UnitedHealth

Over the last 16 years, insiders at UnitedHealth have traded over $377,515,600 worth of UnitedHealth stock and bought 8,472,705 units worth $477,578,867 . The most active insider traders include Stephen J Hemsley, Edson De Godoy Bueno, and Richard T Burke. On average, UnitedHealth executives and independent directors trade stock every 14 days with the average trade being worth of $23,539,464. The most recent stock trade was executed by Richard T Burke on 16 October 2019, trading 25,000 units of UNH stock currently worth $5,914,000.

What does UnitedHealth do?

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health services business serving the broad health care marketplace, including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the health care industry. The OptumRx segment provides pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minneapolis, MN.

What does UnitedHealth’s logo look like?

UnitedHealth executives and stock owners

UnitedHealth executives and other stock owners filed with the SEC include:

• Andrew Witty, Chief Executive Officer of Optum, Executive Vice President, Director
• David Wichmann, Chief Executive Officer, Director
• Stephen Hemsley, Executive Chairman of the Board
• John Rex, Chief Financial Officer, Executive Vice President
• Marianne Short, Executive Vice President, Chief Legal Officer
• D. Ellen Wilson, Executive Vice President – Human Capital
• Richard Burke, Lead Independent Director
• Glenn Renwick, Independent Director
• Michele Hooper, Independent Director
• Gail Wilensky, Independent Director
• Timothy Flynn, Independent Director
• William Ballard, Independent Director
• Valerie Montgomery Rice, Independent Director
• F. William McNabb, Independent Director
• Frances Jacobs, IR Contact Officer
• John Noseworthy, Independent Director
• Thomas Roos, Senior Vice President, Chief Accounting Officer
• Dirk C Mc Mahon, President & CEO, UHC
• Edson De Godoy Bueno, Director
• Robert J Darretta, Director
• Rodger A Lawson, Director
• Kenneth Irwin Shine, Director
• Larry C Renfro, EVP, UHG & CEO, Ovations
• Steven H Nelson, EVP & CEO, UnitedHealthcare
• William A Munsell, CEO, Specialized Care Services
• Thomas H Kean, Director
• William W Mcguire, Chairman & CEO
• Mitchell Eliot Zamoff, EVP and General Counsel
• Anthony Welters, EVP & Pres Publc & Sr Mkts Grp
• Richard H Anderson, CEO, Ingenix
• Tracy L Bahl, CEO, Uniprise, Inc.
• Richard N Baer, EVP & Chief Legal Officer
• Patrick J Erlandson, Chief Financial Officer
• Reed Vaughn Tuckson, EVP & Chief of Medical Affairs
• Thomas L Strickland, EVP & Chief Legal Officer
• William G Spears, Director
• James A /Dc/ Johnson, Director
• Mary Oneil Mundinger, Director
• George Lawrence Iii Mikan, EVP and CFO
• Gail Boudreaux, EVP & Pres, UnitedHealthcare
• Robert J Sheehy, CEO, UnitedHealthcare
• Robert L Ryan, Director
• Christopher James Walsh, EVP and General Counsel
• Forrest Gregory Burke, Acting General Counsel
• R Channing Wheeler, CEO, Uniprise, Inc.
• Douglas W Leatherdale, Director
• Eric S Rangen, Sr VP & Chief Acctg Officer
• Donna E Shalala, Director
• David J Lubben, Secretary and General Counsel
• Lois E Quam, CEO, Ovations, Inc.
• Lori Sweere, EVP, Human Capital